Results 231 to 240 of about 516,976 (376)
Generating the polymorph landscapes of amyloid fibrils using AI: RibbonFold. [PDF]
Guo L+5 more
europepmc +1 more source
Lymphoid cells in endotoxin-induced production of the amyloid-related serum amyloid A protein [PDF]
David L. Rosenstreich+1 more
openalex +1 more source
Abstract INTRODUCTION Specific features of subjective cognitive decline (SCD‐plus) have been proposed to indicate an increased risk of preclinical Alzheimer's disease (AD). However, few studies have examined how these features relate to AD biomarkers in cognitively unimpaired (CU) older adults. METHODS Meta‐analyses were performed using cross‐sectional
Elizabeth Kuhn+38 more
wiley +1 more source
Inhibition of cytotoxic fibril formation of α-synuclein and human insulin by Silymarin from the Silybum marianum. [PDF]
Moosakhani B+6 more
europepmc +1 more source
Abstract US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This evidence‐based guideline was developed to empower all—including primary care—clinicians to implement a structured approach for evaluating a ...
Alireza Atri+10 more
wiley +1 more source
Fabrication and Functionalisation of Nanocarbon‐Based Field‐Effect Transistor Biosensors
Next‐generation diagnostics: Nanocarbon‐based field effect transistors (NC‐FETs) use incoming target analytes to impart a gating effect on conductance. Here, we review the operational mechanisms behind NC‐FETs, the fabrication and functionalisation of NC‐FETs with receptor biomolecules and downstream biosensing applications.
Chang‐Seuk Lee+4 more
wiley +1 more source
The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer's disease based solely on biomarker evidence. [PDF]
Planche V+8 more
europepmc +1 more source
A CASE OF SUBGLOTTIC GRANULOMA WITH AMYLOID DEGENERATION
SCHOICHI NANJYO, Akio Suga, M. HOSUI
openalex +2 more sources